Dr. Thomas Abraham Samuel, MD

Dr. Samuel practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Samuel's NPI, 1831187947, was assigned on October 12, 2005. Dr. Samuel graduated from Renaissance School of Medicine at Stony Brook University in 1998. Dr. Samuel holds Florida license ME112945.

Dr. Samuel's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Samuel's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Samuel is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Samuel to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samuel practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Samuel's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Samuel is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Samuel's licenses on file in 3 states: Florida, Georgia and Pennsylvania.

Dmand AI lists breast cancer, chronic leukemia, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Samuel treats.

CMS data shows 520 Medicare services from Dr. Samuel across 4 procedure codes in 2024, for 139 Medicare patients. Medicare paid $43,083 for them.

CMS counts 139 Medicare patients who saw Dr. Samuel in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Samuel's median patient age at 66, with 91% women.

In 2024, Dr. Samuel wrote 828 Medicare Part D claims for 174 patients. 90% of them were for generic drugs. CMS names the drug for 669 of them, across 16 drugs with 11 or more claims each, at $656,486 in total drug cost. In 2023, CMS named 734 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Samuel for performance year 2024, reported through an alternative payment model (APM). Dr. Samuel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Samuel as offering telehealth.

Dmand AI links 7 papers to Dr. Samuel, published from 2013 to 2023. 2017 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents. Dr. Samuel's most frequent co-authors are Zeina Ahmad Nahleh, MD, Elizabeth R. Stone, MD and Wesam Ahmed, MD.

Dmand AI links Dr. Samuel to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 100 general payments to Dr. Samuel from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $318.

Dr. Samuel graduated from Renaissance School of Medicine at Stony Brook University in 1998.

Dr. Samuel is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.